New Key Statistics Module, Z-Score and F-Score
NAS:EPIX Key Ratios
| Market Cap $ M | 9.52 |
| Enterprise Value $ M | -100.10 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | -- |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -0.56 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -- |
| EV-to-EBITDA | -- |
| PEG | -- |
| Shares Outstanding M | 47.31 |
| Net Margin (%) | -- |
| Operating Margin % | -- |
| Pre-tax Margin (%) | -- |
| Quick Ratio | -- |
| Current Ratio | -- |
| ROA % (ttm) | -- |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -- |
| Dividend Yield % | -- |
| Altman Z-Score | -- |
EPIX Number of Guru Trades
EPIX Volume of Guru Trades
Gurus Latest Trades with NAS:EPIX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:EPIX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
ESSA Pharma Inc Insider Transactions
No Available Data
Guru Commentaries on NAS:EPIX
Clark Street Value
Neutral
2025 Q2
What the manager wrote
ESSA Pharma (EPIX) is trading for $1.75/share and my estimate of its liquidation value is approximately $2.10/share. 9.5% shareholder BML and 5.1% shareholder Soleus Capital Management have both written public letters to the board pushing for a liquidation. Kevin Tang is also here with a 9.7% stake, but BVF Partners is the largest shareholder at 20%. In the Q1 results (filed after the Soleus & BML letters), EPIX included the line 'we have taken productive steps towards a decision and hope to share an update in the near future.' That was 53 days ago, hopefully a resolution will take place shortly.
News about NAS:EPIX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers